Bugs as Drugs, potential self-regenerated innovative cancer therapeutics approach for global health

Abstract

Microbial-based cancer therapy have the potential to provide new cancer immunotherapy opportunities for people from Low-and Middle-Income countries

Enhancing the Anticancer Activity of Attenuated Listeria monocytogenes by Cell Wall Functionalization with 'Clickable' Doxorubicin

“…The use of bacteria as immunotherapeutic agents has exploded in recent decades, mainly because these organisms can accumulate selectively in the cancer microenvironment, but also because they are straightforward to manipulate and inexpensive. Therefore, immunotherapeutic bacteria are a sustainable option, especially for low-medium income countries 43 . With the aim to further increase their anticancer activity, bacteria have also been exploited as delivery platforms 44 45 .…”